VIMENTIN; CHKX-50UL

Code: ab5733 D2-231

Not available outside of the UK & Ireland.

Analysis Note

ControlBreast carcinoma tissue, Colon, Prostate, Tonsil, Tonsilar lymphoma, Uterus, Ureter

Application

Research Sub CategoryCytoske...


read more

Your Price
£364.00 EACH

Not available outside of the UK & Ireland.

Analysis Note

ControlBreast carcinoma tissue, Colon, Prostate, Tonsil, Tonsilar lymphoma, Uterus, Ureter

Application

Research Sub CategoryCytoskeleton

Detect Vimentin using this Anti-Vimentin Antibody validated for use in IC.

Research CategoryCell Structure

Immunocytochemistry: 1:1,000-1:5,000

Optimal working dilutions must be determined by the end user.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Immunogen

Recombinant vimentin.

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Other Notes

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Physical form

Chicken IgY in PBS with 5 mM sodium azide as a preservative.

Unpurified

Specificity

Recognizes Vimentin.

Storage and Stability

Maintain for 1 year at -20°C from date of shipment. Aliquot to avoid repeated freezing and thawing. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

antibody formserum
antibody product typeprimary antibodies
biological sourcechicken
clonepolyclonal
Gene Informationhuman ... VIM(7431)
manufacturer/tradenameChemicon®
NCBI accession no.NM_003380.2
Quality Level100
shipped indry ice
species reactivityhuman, feline, mouse, chicken, rat
technique(s)immunocytochemistry: suitable
UniProt accession no.P08670
This product has met the following criteria: